Company profile
Entrada Therapeutics
Innovating to transform the treatment of serious diseases through establishing a new class of genetic medicines.
- Industry
- Biotechnology Research
- Employees
- 207
- Headquarters
- Boston, MA
- Founded
- 2016
- LinkedIn followers
- 35,420
- Office locations
- 1
Entrada Therapeutics company summary
Entrada Therapeutics is a company in the Biotechnology Research industry, headquartered in Boston, MA, founded in 2016. On LinkedIn the company has around 207 employees and 35,420 followers.
What technology does Entrada Therapeutics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Entrada Therapeutics
Headquartered in Boston’s Seaport community, Entrada Therapeutics is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of genetic medicines that engage intracellular targets that have long been considered inaccessible. Through proprietary, versatile and modular approaches, we are advancing a robust development portfolio of genetic medicines for the potential treatment of neuromuscular and inherited retinal diseases, among others. Our lead oligonucleotide programs are in development for the potential treatment of people living with Duchenne muscular dystrophy who are exon 44, 45, 50 and 51 skipping amenable. Entrada has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1. For more information about Entrada, please visit our website, www.entradatx.com
Where is Entrada Therapeutics located?
Entrada Therapeutics lists 1 location.
Compare companies similar to Entrada Therapeutics
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Entrada Therapeutics entradatx.com | Biotechnology Research | 207 | 2016 | Boston, MA |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Entrada Therapeutics
What does Entrada Therapeutics do?
Headquartered in Boston’s Seaport community, Entrada Therapeutics is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of genetic medicines that engage intracellular targets that have long been considered inaccessible. Through proprietary, versatile and modular approaches, we are advancing a robust development portfolio of genetic medicines for the potential treatment of neuromuscular and inherited retinal diseases, among others. Our lead oligonucleotide programs are in development for the potential treatment of people living with Duchenne muscular dystrophy who are exon 44, 45, 50 and 51 skipping amenable. Entrada has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1. For more information about Entrada, please visit our website, www.entradatx.com
How many employees does Entrada Therapeutics have?
Entrada Therapeutics has around 207 employees on LinkedIn.
Where is Entrada Therapeutics headquartered?
Entrada Therapeutics is headquartered in Boston, MA.
When was Entrada Therapeutics founded?
Entrada Therapeutics was founded in 2016.
Build a lead list from companies like Entrada Therapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.